69 related articles for article (PubMed ID: 2491283)
1. [Reactivation of virus replication during immunosuppressive therapy in children with chronic hepatitis B].
Giacchino R; Facco F; Loy A; Timitilli A; Cirillo C; Navone C; Ciravegna B; Pisani N
Boll Ist Sieroter Milan; 1989; 68(1):24-7. PubMed ID: 2491283
[TBL] [Abstract][Full Text] [Related]
2. Serum HBV-DNA (hepatitis B virus DNA) in acute and chronic hepatitis B infection.
Feinman SV; Berris B; Fay O; Sooknanan R; Tanno HE; Tung WW; Lieberman HM
Clin Invest Med; 1988 Aug; 11(4):286-91. PubMed ID: 3168350
[TBL] [Abstract][Full Text] [Related]
3. [Serum DNA of hepatitis B virus in children with chronic infection].
Codoñer P; Brines J; Bernard O; Hadchouel M; Alagille D; Scotto J
An Esp Pediatr; 1986 Feb; 24(2):98-104. PubMed ID: 3963659
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
[TBL] [Abstract][Full Text] [Related]
5. [HBe antigen and B virus DNA in patients with chronic active hepatitis].
Chaussade S; Thiers V; Boboc B; Housset C; Bréchot C; Degos F
Gastroenterol Clin Biol; 1986 Nov; 10(11):744-7. PubMed ID: 3803809
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
7. [Course of chronic hepatitis related to B virus in children. Study of serum viral DNA].
Codoñer Franch PC; Scotto J; Hadchouel M; Bernard O; Alagille D
Gastroenterol Clin Biol; 1985; 9(6-7):516-21. PubMed ID: 4018486
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus DNA detected by PCR in sera and liver tissues of Chinese patients with chronic liver diseases.
Zhang YY; Guo LS; Li L; Zhang YD; Hao LJ; Hansson BG; Nordenfelt E
Chin Med J (Engl); 1993 Jan; 106(1):7-12. PubMed ID: 8504690
[TBL] [Abstract][Full Text] [Related]
9. Different levels of hepatitis B virus replication among hepatitis Be antigen-positive chronic carriers.
Bartolomé J; Castillo I; Mora I; Gutiez J; Porres JC; Carreño V
Acta Virol; 1988 May; 32(3):193-7. PubMed ID: 2902767
[TBL] [Abstract][Full Text] [Related]
10. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
11. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
[TBL] [Abstract][Full Text] [Related]
12. [Viral nucleic acids in the serum of hepatitis B patients].
Hofmann H; Tuma W; Heinz FX; Kunz C
Wien Klin Wochenschr; 1988 Jan; 100(2):52-5. PubMed ID: 3348042
[TBL] [Abstract][Full Text] [Related]
13. Contrasting patterns of response to lamivudine monotherapy in chronic hepatitis B patients.
Wolters LM; van Nunen AB; Niesters HG; de Man RA
Scand J Gastroenterol Suppl; 2000; (232):74-8. PubMed ID: 11232497
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of immunotherapy with vaccination against hepatitis B virus on virus B multiplication].
Pol S; Driss F; Carnot F; Michel ML; Berthelot P; Brechot C
C R Acad Sci III; 1993 Jul; 316(7):688-91. PubMed ID: 8019891
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
Vassiliadis T; Garipidou V; Tziomalos K; Perifanis V; Giouleme O; Vakalopoulou S
Am J Hematol; 2005 Nov; 80(3):197-203. PubMed ID: 16247746
[TBL] [Abstract][Full Text] [Related]
16. Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B.
Mihm U; Sarrazin C; Herrmann E; Teuber G; von Wagner M; Kronenberger B; Zeuzem S
Z Gastroenterol; 2003 Mar; 41(3):249-54. PubMed ID: 12664345
[TBL] [Abstract][Full Text] [Related]
17. Study of relativity between HBV M and HBV DNA in the cases with hepatitis B.
Meng Q; Liang R; Liu D
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):352-4. PubMed ID: 11471024
[TBL] [Abstract][Full Text] [Related]
18. [Severe exacerbation of chronic hepatitis B following interferon therapy].
Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatitis B virus-DNA in chronic hepatitis B and delta infection.
Govindarajan S; Valinluck B
Arch Pathol Lab Med; 1985 May; 109(5):398-9. PubMed ID: 3838652
[TBL] [Abstract][Full Text] [Related]
20. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
